{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T20:41:53Z","timestamp":1790023313759,"version":"4.0.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1124\/jpet.108.139543","type":"journal-article","created":{"date-parts":[[2008,5,8]],"date-time":"2008-05-08T01:36:36Z","timestamp":1210210596000},"page":"363-368","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":194,"title":["Mineral Arsenicals in Traditional Medicines: Orpiment, Realgar, and Arsenolite"],"prefix":"10.1016","volume":"326","author":[{"given":"Jie","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanfu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Goyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Waalkes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.108.139543_bib1","unstructured":"Agency for Toxic Substances and Disease Registry (2005) Toxicological Profile for Arsenic (Update). Agency for Toxic Substances and Disease Registry, Atlanta, GA."},{"key":"10.1124\/jpet.108.139543_bib2","doi-asserted-by":"crossref","unstructured":"Borak J and Hosgood HD (2007) Seafood arsenic: implications for human risk assessment. Regul Toxicol Pharmacol 47: 204\u2013412.","DOI":"10.1016\/j.yrtph.2006.09.005"},{"key":"10.1124\/jpet.108.139543_bib3","doi-asserted-by":"crossref","unstructured":"Carter DE, Aposhian HV, and Gandolfi AJ (2003) The metabolism of inorganic arsenic oxides, gallium arsenide, and arsine: a toxicochemical review. Toxicol Appl Pharmacol 193: 309\u2013334.","DOI":"10.1016\/j.taap.2003.07.009"},{"key":"10.1124\/jpet.108.139543_bib4","unstructured":"Chen SY, Li XM, and Liu SX (2000) A review of the research on malignant hemopathies treated with arsenic-containing Chinese drugs. Zhongguo Zhong Yao Za Zhi 25: 454\u2013473."},{"key":"10.1124\/jpet.108.139543_bib5","unstructured":"Chinese Pharmacopeia Committee (2005) Pharmacopoeia of China. People\u2019s Press, Beijing, China."},{"key":"10.1124\/jpet.108.139543_bib6","doi-asserted-by":"crossref","unstructured":"Chou WC and Dang CV (2005) Acute promyelocytic leukemia: recent advances in therapy and molecular basis of response to arsenic therapies. Curr Opin Hematol 12: 1\u20136.","DOI":"10.1097\/01.moh.0000148552.93303.45"},{"key":"10.1124\/jpet.108.139543_bib7","doi-asserted-by":"crossref","unstructured":"Cooper K, Noller B, Connell D, Yu J, Sadler R, Olszowy H, Golding G, Tinggi U, Moore MR, and Myers S (2007) Public health risks from heavy metals and metalloids. J Toxicol Environ Health A 70: 1694\u20131699.","DOI":"10.1080\/15287390701434885"},{"key":"10.1124\/jpet.108.139543_bib8","doi-asserted-by":"crossref","unstructured":"Efferth T, Li PC, Konkimalla VS, and Kaina B (2007) From traditional Chinese medicine to rational cancer therapy. Trends Mol Med 13: 353\u2013361.","DOI":"10.1016\/j.molmed.2007.07.001"},{"key":"10.1124\/jpet.108.139543_bib9","doi-asserted-by":"crossref","unstructured":"Ernst E (2002) Toxic heavy metals and undeclared drugs in Asian herbal medicines. Trends Pharmacol Sci 23: 136\u2013139.","DOI":"10.1016\/S0165-6147(00)01972-6"},{"key":"10.1124\/jpet.108.139543_bib10","doi-asserted-by":"crossref","unstructured":"Evens AM, Tallman MS, and Gartenhaus RB (2004) The potential of arsenic trioxide in the treatment of malignant disease: past, present, and future. Leuk Res 28: 891\u2013900.","DOI":"10.1016\/j.leukres.2004.01.011"},{"key":"10.1124\/jpet.108.139543_bib11","doi-asserted-by":"crossref","unstructured":"Floroiu RM and Davis AP (2004) Torrents A. Kinetics and mechanism of As2S3(am) dissolution under N2. Environ Sci Technol 38: 1031\u20131037.","DOI":"10.1021\/es034292q"},{"key":"10.1124\/jpet.108.139543_bib12","doi-asserted-by":"crossref","unstructured":"Fujisawa S, Ohno R, Shigeno K, Sahara N, Nakamura S, Naito K, Kobayashi M, Shinjo K, Takeshita A, Suzuki Y, et al. (2007) Pharmacokinetics of arsenic species in Japanese patients with relapsed or refractory acute promyelocytic leukemia treated with arsenic trioxide. Cancer Chemother Pharmacol 59: 485\u2013493.","DOI":"10.1007\/s00280-006-0288-4"},{"key":"10.1124\/jpet.108.139543_bib13","doi-asserted-by":"crossref","unstructured":"Hede K (2007) Chinese folk treatment reveals power of arsenic to treat cancer, new studies under way. J Natl Cancer Inst 99: 667\u2013678.","DOI":"10.1093\/jnci\/djk191"},{"key":"10.1124\/jpet.108.139543_bib14","unstructured":"IARC (2004) Some Drinking Water Disinfectants and Contaminants, including Arsenic, Vol. 84, pp 269\u2013247, IARC (International Agency for Research on Cancer Monographs on Evaluation of Carcinogenic Risk to Humans) Press, Lyon, France."},{"key":"10.1124\/jpet.108.139543_bib15","doi-asserted-by":"crossref","unstructured":"Koch I, Sylvester S, Lai VW, Owen A, Reimer KJ, and Cullen WR (2007) Bioaccessibility and excretion of arsenic in Niu Huang Jie Du Pian pills. Toxicol Appl Pharmacol 222: 357\u2013364.","DOI":"10.1016\/j.taap.2006.12.005"},{"key":"10.1124\/jpet.108.139543_bib16","doi-asserted-by":"crossref","unstructured":"Kreppel H, Bauman JW, Liu J, McKim JM Jr., and Klaassen CD (1993) Induction of metallothionein by arsenicals in mice. Fundam Appl Toxicol 20: 184\u2013189.","DOI":"10.1093\/toxsci\/20.2.184"},{"key":"10.1124\/jpet.108.139543_bib17","doi-asserted-by":"crossref","unstructured":"Kumana CR, Au WY, Lee NS, Kou M, Mak RW, Lam CW, and Kwong YL (2002) Systemic availability of arsenic from oral arsenic-trioxide used to treat patients with hematological malignancies. Eur J Clin Pharmacol 58: 521\u2013526.","DOI":"10.1007\/s00228-002-0514-x"},{"key":"10.1124\/jpet.108.139543_bib18","doi-asserted-by":"crossref","unstructured":"Kumar A, Nair AG, Reddy AV, and Garg AN (2006) Bhasmas: unique ayurvedic metallic-herbal preparations, chemical characterization. Biol Trace Elem Res 109: 231\u2013254.","DOI":"10.1385\/BTER:109:3:231"},{"key":"10.1124\/jpet.108.139543_bib19","doi-asserted-by":"crossref","unstructured":"Lantz RC, Parliman G, Chen GJ, Barber D, Winski S, and Carter DE (1995) Effect of arsenic exposure on alveolar macrophage function. II. Effect of slightly soluble forms of As(III) and As(V). Environ Res 68: 59\u201367.","DOI":"10.1006\/enrs.1995.1008"},{"key":"10.1124\/jpet.108.139543_bib20","doi-asserted-by":"crossref","unstructured":"Lin M, Wang Z, and Zhang D (2007) Preparation of orpiment nanoparticles and their cytotoxic effect on cultured leukemia K562 cells. J Nanosci Nanotechnol 7: 490\u2013496.","DOI":"10.1166\/jnn.2007.145"},{"key":"10.1124\/jpet.108.139543_bib21","unstructured":"Liu J, Goyer R, Waalkes MP (2007) Toxic effects of metals, in: Casarett and Doull\u2019s Toxicology\u2014The Basic Science of Poisons, 7th Ed (Klaassen CD ed), pp 931\u2013979, McGraw Hill, New York."},{"key":"10.1124\/jpet.108.139543_bib22","doi-asserted-by":"crossref","unstructured":"Lu DP, Qiu JY, Jiang B, Wang Q, Liu KY, Liu YR, and Chen SS (2002) Tetra-arsenic tetra-sulfide for the treatment of acute promyelocytic leukemia: a pilot report. Blood 99: 3136\u20133143.","DOI":"10.1182\/blood.V99.9.3136"},{"key":"10.1124\/jpet.108.139543_bib23","doi-asserted-by":"crossref","unstructured":"Maeda H, Hori S, Ohizumi H, Segawa T, Kakehi Y, Ogawa O, and Kakizuka A (2004) Effective treatment of advanced solid tumors by the combination of arsenic trioxide and l-buthionine-sulfoximine. Cell Death Differ 11: 737\u2013746.","DOI":"10.1038\/sj.cdd.4401389"},{"key":"10.1124\/jpet.108.139543_bib24","doi-asserted-by":"crossref","unstructured":"Marafante E and Vahter M (1987) Solubility, retention, and metabolism of intratracheally and orally administered inorganic arsenic compounds in the hamster. Environ Res 42: 72\u201382.","DOI":"10.1016\/S0013-9351(87)80008-7"},{"key":"10.1124\/jpet.108.139543_bib25","unstructured":"Miller WH Jr, Schipper HM, Lee JS, Singer J, and Waxman S (2002) Mechanisms of action of arsenic trioxide. Cancer Res 62: 3893\u20133903."},{"key":"10.1124\/jpet.108.139543_bib26","doi-asserted-by":"crossref","unstructured":"Mitra A, Chakraborty S, Auddy B, Tripathi P, Sen S, Saha AV, and Mukherjee B (2002) Evaluation of chemical constituents and free-radical scavenging activity of Swarnabhasma (gold ash), an ayurvedic drug. J Ethnopharmacol 80: 147\u2013153.","DOI":"10.1016\/S0378-8741(02)00008-9"},{"key":"10.1124\/jpet.108.139543_bib27","unstructured":"National Research Council (1999) Arsenic in the Drinking Water, National Academy, Washington, DC."},{"key":"10.1124\/jpet.108.139543_bib28","unstructured":"Qin XY, Jiang B, Li GX, and Lu DP (2006) Chronic hepatic damage in acute promyelocytic leukemia patients treated with tetra-arsenic tetra-sulfide. Zhonghua Xue Ye Xue Za Zhi 27: 259\u2013263."},{"key":"10.1124\/jpet.108.139543_bib29","doi-asserted-by":"crossref","unstructured":"Shen ZX, Chen GQ, Ni JH, Li XS, Xiong SM, Qiu QY, Zhu J, Tang W, Sun GL, Yang KQ, et al. (1997) Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients. Blood 89: 3354\u20133360.","DOI":"10.1182\/blood.V89.9.3354"},{"key":"10.1124\/jpet.108.139543_bib30","unstructured":"Shen JC, Liu KY, Jiang B, Lu XJ, and Lu DP (2004) Effect of the tetra-arsenic tetra-sulfide (As4S4) on the corrected QT interval in the treatment of acute promyelocytic leukemia. Zhonghua Xue Ye Xue Za Zhi 25: 359\u2013361."},{"key":"10.1124\/jpet.108.139543_bib31","unstructured":"Tang YS and Wang LS (2005) Pharmacokinetic studies of arsenic-containing traditional medicines. Zhong Yao Cai 12: 1130\u20131135."},{"key":"10.1124\/jpet.108.139543_bib32","doi-asserted-by":"crossref","unstructured":"Tinwell H, Stephens SC, and Ashby J (1991) Arsenite as the probable active species in the human carcinogenicity of arsenic: mouse micronucleus assays on Na and K arsenite, orpiment, and Fowler\u2019s solution. Environ Health Perspect 95: 205\u2013210.","DOI":"10.1289\/ehp.9195205"},{"key":"10.1124\/jpet.108.139543_bib33","doi-asserted-by":"crossref","unstructured":"Vantroyen B, Heilier JF, Meulemans A, Michels A, Buchet JP, Vanderschueren S, Haufroid V, and Sabbe M (2004) Survival after a lethal dose of arsenic trioxide. J Toxicol Clin Toxicol 42: 889\u2013895.","DOI":"10.1081\/CLT-200035344"},{"key":"10.1124\/jpet.108.139543_bib34","unstructured":"Wang LM (2005) Chronic arsenic poisoning caused by long-term taken Niuhuang Ninggong tablet: a report of 2 cases. Zhongguo Zhong Xi Yi Jie He Za Zhi 25: 213\u2013215."},{"key":"10.1124\/jpet.108.139543_bib35","doi-asserted-by":"crossref","unstructured":"Wang L, Zhou GB, Liu P, Song JH, Liang Y, Yan XJ, Xu F, Wang BS, Mao JH, Shen ZX, et al. (2008) Dissection of mechanisms of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia. Proc Natl Acad Sci U S A 105: 4826\u20134831.","DOI":"10.1073\/pnas.0712365105"},{"key":"10.1124\/jpet.108.139543_bib36","doi-asserted-by":"crossref","unstructured":"Westervelt P, Brown RA, Adkins DR, Khoury H, Curtin P, Hurd D, Luger SM, Ma MK, Ley TJ, and DiPersio JF (2001) Sudden death among patients with acute promyelocytic leukemia treated with arsenic trioxide. Blood 98: 266\u2013271.","DOI":"10.1182\/blood.V98.2.266"},{"key":"10.1124\/jpet.108.139543_bib37","doi-asserted-by":"crossref","unstructured":"Wu JZ and Ho PC (2006) Evaluation of the in vitro activity and in vivo bioavailability of realgar nanoparticles prepared by cryo-grinding. Eur J Pharm Sci 29: 35\u201344.","DOI":"10.1016\/j.ejps.2006.05.002"},{"key":"10.1124\/jpet.108.139543_bib38","doi-asserted-by":"crossref","unstructured":"Wu MH, Lin CJ, Chen CL, Su MJ, Sun SS, and Cheng AL (2003) Direct cardiac effects of As2O3 in rabbits: evidence of reversible chronic toxicity and tissue accumulation of arsenicals after parenteral administration. Toxicol Appl Pharmacol 189: 214\u2013220.","DOI":"10.1016\/S0041-008X(03)00127-3"},{"key":"10.1124\/jpet.108.139543_bib39","doi-asserted-by":"crossref","unstructured":"Yamamoto A, Hisanaga A, and Ishinishi N (1987) Tumorigenicity of inorganic arsenic compounds following intratracheal instillations to the lungs of hamsters. Int J Cancer 40: 220\u2013223.","DOI":"10.1002\/ijc.2910400216"},{"key":"10.1124\/jpet.108.139543_bib40","doi-asserted-by":"crossref","unstructured":"Yu J, Qian H, Li Y, Wang Y, Zhang X, Liang X, Fu M, and Lin C (2007) Arsenic trioxide (As2O3) reduces the invasive and metastatic properties of cervical cancer cells in vitro and in vivo. Gynecol Oncol 106: 400\u2013406.","DOI":"10.1016\/j.ygyno.2007.04.016"},{"key":"10.1124\/jpet.108.139543_bib41","unstructured":"Zhang W, Yu BY, Kou JP, and Wang JR (2004) Studies on the correlation between toxicity and activities of realgar. Chin J Nat Med 2: 123\u2013125."}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524345306?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524345306?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.108.139543","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T22:42:11Z","timestamp":1740004931000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524345306"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["S0022356524345306"],"URL":"https:\/\/doi.org\/10.1124\/jpet.108.139543","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2008,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mineral Arsenicals in Traditional Medicines: Orpiment, Realgar, and Arsenolite","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.108.139543","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2008 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}